Evidence map›Paper›PMID 34775575›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2022

Escherichia coli carrying bla

Priscila L Wink, Daiana Lima-Morales, Rafael Meurer, Afonso L Barth

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Priscila L Wink *Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2350, Porto Alegre, RS, 90.035-903, Brazil.
Daiana Lima-Morales *Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2350, Porto Alegre, RS, 90.035-903, Brazil.
Rafael MeurerCurso de Especialização em Microbiologia Clínica, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Afonso L BarthLaboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2350, Porto Alegre, RS, 90.035-903, Brazil. albarth@hcpa.edu.br.
Hospital de Clínicas de Porto Alegre · BRR3 Animal · BRUniversidade Federal do Rio Grande do Sul · BR

Funding

conselho nacional de desenvolvimento científico e tecnológico 465718/2014-0fipe, hcpa 2019-0203fundação de amparo à pesquisa do estado do rio grande do sul 17/2551-0000514-7
6 · The paper itself

Abstract

The reservoirs for NDM-producing Enterobacterales are increasing, not only in hospitals, but also in the environment and in the community, challenging the therapeutic efficacy of carbapenems. We aimed to characterize an isolate of Escherichia coli harboring the bla

Indexed as

Escherichia coli InfectionsSpheniscidaeAnimalsAnti-Bacterial Agentsbeta-LactamasesBrazilDrug Resistance, Multiple, BacterialEscherichia coliMicrobial Sensitivity TestsPlasmidsAnti-Bacterial Agentsbeta-lactamase NDM-1beta-LactamasesAntimicrobial resistanceCarbapenem resistanceNDM-1PenguinST156Wildlife

Identifiers

PMID34775575
PMCPMC8882513
OpenAlexW3212438931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.